13-45151783-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004128.3(GTF2F2):c.256C>G(p.Gln86Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000479 in 1,585,466 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004128.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GTF2F2 | NM_004128.3 | c.256C>G | p.Gln86Glu | missense_variant | Exon 4 of 8 | ENST00000340473.8 | NP_004119.1 | |
GTF2F2 | XM_011535052.4 | c.256C>G | p.Gln86Glu | missense_variant | Exon 4 of 9 | XP_011533354.1 | ||
GTF2F2 | XM_011535053.4 | c.256C>G | p.Gln86Glu | missense_variant | Exon 4 of 6 | XP_011533355.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GTF2F2 | ENST00000340473.8 | c.256C>G | p.Gln86Glu | missense_variant | Exon 4 of 8 | 1 | NM_004128.3 | ENSP00000340823.6 | ||
GTF2F2 | ENST00000706694.1 | n.85C>G | non_coding_transcript_exon_variant | Exon 1 of 6 | ENSP00000516507.1 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 151918Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000581 AC: 14AN: 241072Hom.: 0 AF XY: 0.0000384 AC XY: 5AN XY: 130344
GnomAD4 exome AF: 0.0000251 AC: 36AN: 1433548Hom.: 0 Cov.: 25 AF XY: 0.0000224 AC XY: 16AN XY: 714284
GnomAD4 genome AF: 0.000263 AC: 40AN: 151918Hom.: 0 Cov.: 31 AF XY: 0.000216 AC XY: 16AN XY: 74176
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.256C>G (p.Q86E) alteration is located in exon 4 (coding exon 4) of the GTF2F2 gene. This alteration results from a C to G substitution at nucleotide position 256, causing the glutamine (Q) at amino acid position 86 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at